Both of those countries have been viewed as having considerably weaker intellectual property protection than Canada.
The observation I was making with respect to us lagging is that as we go forward.... Already China is essentially by volume the largest R and D country in the world--and not surprisingly. They have the population. They now have the educated population. They now have the market.
China is already an upper-middle-income country, as identified by the OECD. My contention is that as these countries mature economically, they are going to demand the type of high-quality, leading-edge innovation that we in North America and western Europe have taken for granted for a number of decades, and it's going to be in their interests at that stage to protect their investment, being the leading R and D producers.
I'm just suggesting that we don't want to be left behind with even weaker than their newly determined level of protection. We're already in a vulnerable situation. We don't have the R and D we would like to have, certainly in the pharmaceutical area, relative to Europe and the United States. When those other countries come on we're going to be that much further behind.
So let's at least try to make ourselves at an internationally recognized level of IP protection.